SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001851734-21-000109
Filing Date
2021-11-16
Accepted
2021-11-16 17:04:48
Documents
15
Period of Report
2021-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fwbi20211116_8k.htm   iXBRL 8-K 25748
2 EXHIBIT 10.1 ex_308440.htm EX-10.1 25465
3 EXHIBIT 99.1 ex_308441.htm EX-99.1 9029
  Complete submission text file 0001851734-21-000109.txt   206546

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20211115.xsd EX-101.SCH 3594
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fwbi-20211115_def.xml EX-101.DEF 11805
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20211115_lab.xml EX-101.LAB 15849
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20211115_pre.xml EX-101.PRE 12020
8 EXTRACTED XBRL INSTANCE DOCUMENT fwbi20211116_8k_htm.xml XML 2682
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 211417151
SIC: 2834 Pharmaceutical Preparations